Publication:

Nocturnal gamma-hydroxybutyrate reduces cortisol awakening response and morning kyrunenine pathway metabolites in healthy volunteers

Date

Date

Date
2019
Journal Article
Published version

Citations

Citation copied

Dornbierer, D. A., Boxler, M., Voegel, C. D., Stucky, B., Steuer, A. E., Binz, T. M., Baumgartner, M. R., Baur, D. M., Quednow, B. B., Kraemer, T., Seifritz, E., Landolt, H.-P., & Bosch, O. G. (2019). Nocturnal gamma-hydroxybutyrate reduces cortisol awakening response and morning kyrunenine pathway metabolites in healthy volunteers. International Journal of Neuropsychopharmacology, 22(10), 631–639. https://doi.org/10.1093/ijnp/pyz047

Abstract

Abstract

Abstract

Background Gamma-hydroxybutyrate (GHB; or sodium oxybate) is an endogenous GHB-/GABAB receptor agonist. It is approved for the application in narcolepsy and has been proposed for potential treatment of Alzheimer’s and Parkinson’s disease, fibromyalgia, and depression, all of which involve neuro-immunological processes. Tryptophan catabolites (TRYCATs), the cortisol awakening response (CAR), and brain derived neurotrophic factor (BDNF) have been suggested as peripheral biomarkers of neuropsychiatric disorders. GHB has been shown to in

Metrics

Downloads

1 since deposited on 2019-09-17
Acq. date: 2025-11-12

Views

1 since deposited on 2019-09-17
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
22

Number

Number

Number
10

Page range/Item number

Page range/Item number

Page range/Item number
631

Page end

Page end

Page end
639

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2019-10-01

Date available

Date available

Date available
2019-09-17

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1461-1457

Additional Information

Additional Information

Additional Information
Copyright: Cambridge University Press

OA Status

OA Status

OA Status
Gold

Free Access at

Free Access at

Free Access at
Pubmed ID

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

1 since deposited on 2019-09-17
Acq. date: 2025-11-12

Views

1 since deposited on 2019-09-17
Acq. date: 2025-11-12

Citations

Citation copied

Dornbierer, D. A., Boxler, M., Voegel, C. D., Stucky, B., Steuer, A. E., Binz, T. M., Baumgartner, M. R., Baur, D. M., Quednow, B. B., Kraemer, T., Seifritz, E., Landolt, H.-P., & Bosch, O. G. (2019). Nocturnal gamma-hydroxybutyrate reduces cortisol awakening response and morning kyrunenine pathway metabolites in healthy volunteers. International Journal of Neuropsychopharmacology, 22(10), 631–639. https://doi.org/10.1093/ijnp/pyz047

Gold Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image